Arbutus Enters Exclusivity Agreement with Roivant Sciences

World News: . []

VANCOUVER British Columbia and WARMINSTER Pa Feb 14 2018 GLOBE NEWSWIRE -- Arbutus Biopharma Corporation NasdaqABUS an industry-leading Hepatitis B Virus HBV therapeutic solutions company, announced today that Arbutus and Roivant ent ered in...

More news and information about Arbutus Biopharma Corporation

Published By:

Globe Newswire: 01:50 GMT Thursday 15th February 2018

Published: .

Search for other references to "arbutus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us